This study evaluated the effects of dulaglutide vs placebo on liver and glycaemic/metabolic measurements in a population with Type 2 diabetes and in a subgroup with non-alcoholic fatty liver/non-alcoholic steatohepatitis.Once-weekly dulaglutide improved alanine aminotransferase, aspartate transaminase and gamma-glutamyl transpeptidase levels compared with placebo in a pattern consistent with…

Matthew Gurka, Ph.D., a professor in the Department of Health Outcomes and Biomedical Informatics (HOBI) at UF and associate director of UF’s Institute for Child Health Policy (ICHP), was selected to serve as a member of the National Institutes of Health’s (NIH’s) Kidney, Nutrition, Obesity…

Dr. Sarah Westen, postdoctoral fellow, PHHP department of clinical and health psychology Psychological support is crucial for helping children with Type 1 diabetes and their families manage the disease, yet there are few child psychologists with expertise in the unique aspects of coping with and managing the illness.

Dendritic cell (DC) immunotherapy has been effective for prevention of type 1 diabetes (T1D) in NOD mice but fails to protect if initiated after active autoimmunity. As autoreactivity expands inter- and intramolecularly during disease progression, we investigated whether DCs unpulsed or pulsed with β cell antigenic dominant determinants (DD), subdominant determinants…

To examine the value of percent body fat (%BF) with body mass index (BMI) to assess the risk of abnormal blood glucose (ABG) among US adults who are normal weight or overweight. We hypothesised that normal-weight population with higher %BF is more likely to have ABG.   Read More: http://bmjopen.bmj.com/content/8/4/e019200.long …